aortic regurgitation - Health Topics
MedPage Today: TAVR for Aortic Regurgitation Off to a Good Start in the Real World PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ... TAVR for Aortic Regurgitation Off to a Good Start in the Real World SAN FRANCISCO -- Aortic valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial. The device met the safety benchmark, with a 26.7% rate ...
Understanding the Context
WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ... Medscape: Atrial Fibrillation in Chronic Aortic Regurgitation Linked to Increased Mortality Risk Atrial fibrillation (AF) was present in 1 in 6 patients with chronic aortic regurgitation — either moderate-to-severe or severe — and was independently associated with an increased risk for mortality ... NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ... However, aortic regurgitation (AR) remains an "off-label" indication for TAVR, particularly for patients with mild or absent leaflet calcification or aortic annulus dimensions beyond the size of the ...
Image Gallery
Key Insights
Healio: Novel TAVR system safe, effective for patients with severe aortic regurgitation